Quarterly report pursuant to Section 13 or 15(d)

REVENUE

v3.24.3
REVENUE
6 Months Ended
Jun. 30, 2024
Revenue from Contract with Customer [Abstract]  
REVENUE

4. REVENUE

The Company disaggregates revenue between continuing operations and discontinued operations.  Revenue streams from contracts with customers depicts the nature, amount, timing and uncertainty of its revenue and cash flows as affected by economic factors. Commercial insurance consists of neuromonitoring cases whereby a patient has healthcare insurance that we bill. Facility billing consists of neuromonitoring cases whereby the Company has an agreement to bill the medical facility for patients that do not have health care insurance.  

The Company does not have any contract assets or contract liabilities as of or during the six months ended June 30, 2024, or 2023 or as of December 31, 2023.

The Company’s revenue is as follows (in thousands):

Three Months Ended June 30, 

Six Months Ended June 30, 

2024

    

2023

2024

    

2023

Managed service agreements and other

$

1

$

67

$

10

$

182

Accounts Receivable

A summary of the accounts receivable, net, by revenue stream is as follows (in thousands):

June 30, 

December 31,

    

2024

    

2023

Technical service

$

317

 

$

1,308

Professional service

97

2,293

Arbitration receivable

 

2,887

 

Total receivables, net

$

3,301

$

3,601

The concentration of accounts receivable, net, by payor as a percentage of total accounts receivable is as follows:

As of June 30,

As of December 31,

2024

    

2023

Commercial insurance

100

%

82

%

Facility billing

%

18

%

Total

 

100

%

100

%